Does gender bias prevent women from being treated fairly in job interviews, performance assessments, and other evaluations? Data from an online stock recommendation platform suggests that women’s ideas simply get less attention than their male colleagues’.

A study co-authored by Yale SOM researchers Florian Ederer and Song Ma suggests that “killer acquisitions” by pharmaceutical companies are potentially limiting the number of new treatments available.

A statistical tool that predicts when patients with advanced cancer are likely to die could help promote patient welfare by transferring more people from aggressive interventions to hospice care.

Political polarization is growing and long-established norms that used to serve as landmarks are fading. Experts discuss navigating the challenges of working in and engaging with an administration that has torn up the playbook.

Venture capital investments in more racially integrated cities are more effective, producing more innovation and economic growth. Yale SOM’s Olav Sorenson explains why that might be.

Ebele Ifedigbo ’16, co-founder of The Hood Incubator, discusses how the legal cannabis industry can be a tool for repairing damage done to communities of color by the war on drugs. 

Have political and fiscal debates about higher education lost sight of the value of education for individuals and society?

Yale SOM’s Paul Bracken, an expert on defense strategy, discusses the consequences of a return to a "great power rivalry."

Are we making progress toward a better and more equitable education system? Yale Insights talked with former secretary of education John King, now president and CEO of the Education Trust.

The number of women who die during childbirth is on the decline, but some regions face significant hurdles in making childbirth safer. Dr. Mary-Ann Etiebet ’03, executive director of Merck for Mothers, discusses the state of maternal health.